Sodium Chloride Inhalation Solution, USP, 0.7% 4 mL UDV (UOU)

GUDID 00376204021951

RITEDOSE PHARMACEUTICALS, LLC

Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic Inhalation therapy saline solution, hypertonic

• Primary Device ID: 00376204021951
• NIH Device Record Key: 2639e579-e2bf-4dfb-82e3-f60ca441b804
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: Sodium Chloride Inhalation Solution, USP, 0.7% 4 mL UDV (UOU)
• Version Model Number: 4 mL
• Company DUNS: 968062294
• Company Name: RITEDOSE PHARMACEUTICALS, LLC
• Device Count: 60
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Customer Support Contacts

• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com
• Phone: 1-855-806-3300
• Email: complaints@ritedose.com

Operating and Storage Conditions

• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit
• Storage Environment Temperature: Between 59 Degrees Fahrenheit and 86 Degrees Fahrenheit

Device Identifiers

Device Issuing Agency	Device ID
GS1	00376204021609 [Primary]
GS1	00376204021951 [Unit of Use]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Notification: K210126

FDA Product Code

• CAF: Nebulizer (Direct Patient Interface)

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: true

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2022-01-19
• Device Publish Date: 2022-01-11

Devices Manufactured by RITEDOSE PHARMACEUTICALS, LLC

• 10376204300022 - Sodium Chloride Inhalation Solution, USP, 0.9% 3 mL UDV individually wrapped: 2022-05-24 1 vial per pouch
• 00376204020954 - Sodium Chloride Inhalation Solution, USP, 3.5% 4mL UDV: 2022-01-19
• 00376204021951 - Sodium Chloride Inhalation Solution, USP, 0.7% 4 mL UDV (UOU): 2022-01-19
• 00376204021951 - Sodium Chloride Inhalation Solution, USP, 0.7% 4 mL UDV (UOU): 2022-01-19
• 00376204022958 - Sodium Chloride Inhalation Solution, USP, 3% 4mL UDV: 2022-01-19
• 00376204023955 - Sodium Chloride Inhalation Solution, USP, 10% 4mL UDV: 2022-01-19
• 00376204300018 - Sodium Chloride Inhalation Solution, USP, 0.9% 3 mL UDV individually wrapped: 2021-09-07 One vial per foil pouch
• 00376204300032 - Sodium Chloride Inhalation Solution, USP, 0.9% 3 mL UDV: 2018-03-29
• 00376204300056 - Sodium Chloride Inhalation Solution, USP, 0.9% 5 mL UDV: 2018-03-29